Danish Biotech Firm Alcolase Targets East Asia with Enzyme-Based Solution for Alcohol Intolerance
Korea South, 26th May 2025, – Seoul, South Korea — For nearly 30% of East Asians who suffer from alcohol intolerance — often referred to as “Asian flush” — drinking can trigger symptoms ranging from facial redness and nausea to rapid heartbeat and vomiting. Danish biotech startup Alcolase ApS is developing groundbreaking solution: a patented enzyme supplement that can break down alcohol directly in the stomach, potentially transforming how millions experience alcohol.
Founded in Denmark, Alcolase is developing the world’s first orally active enzyme system specifically designed to counteract ALDH2 deficiency — the genetic cause behind alcohol-induced acetaldehyde buildup. This toxic compound not only causes immediate discomfort but is also associated with increased risks of esophageal, la...